Author:
Sacher Julia,Mossaheb Nilufar,Spindelegger Christoph,Klein Nikolas,Geiss-Granadia Thomas,Sauermann Robert,Lackner Edith,Joukhadar Christian,Müller Markus,Kasper Siegfried
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference69 articles.
1. Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM et al (2005). Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 54: 862–871.
2. American Diabetes Association (2004a). Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (Suppl 1): S5–S10.
3. American Diabetes Association, A.P.A., American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004b). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27: 596–601.
4. Bergman RN (1989). Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. In Diabetes. Vol. 3, Text No. 12, pp 1512–1527 ( http://diabetes.diabetesjournals.org/cgi/content/abstract/38/12/1512 ).
5. Bergman RN, Ader M (2005). Atypical antipsychotics and glucose homeostasis. J Clin Psychiatry 66: 504–514.
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献